Top Stock Reports for Home Depot, Advanced Micro Devices & Pfizer
https://www.zacks.com/commentary/2196642/top-stock-reports-for-home-depot-advanced-micro-devices-pfizer?cid=CS-ZC-FT-research_daily-2196642
Dec 12, 2023 - Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Advanced Micro Devices, Inc. (AMD) and Pfizer Inc. (PFE).
0
Company News for Dec 14, 2023
https://www.zacks.com/stock/news/2197972/company-news-for-dec-14-2023?cid=CS-ZC-FT-corporate_summary-2197972
Dec 14, 2023 - Companies in The News Are: ABM,PFE,HD,GS
0
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
https://www.zacks.com/stock/news/2200645/fda-accepts-merck-s-mrk-bla-for-21-valent-pneumococcal-jab?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200645
Dec 20, 2023 - The FDA grants priority review to Merck's (MRK) filing seeking approval for its 21-valent pneumococcal conjugate vaccine in adults. A final decision is expected in June 2024.
0
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
https://www.zacks.com/stock/news/2201507/pharma-stock-roundup-fda-nod-to-azn-s-eplontersen-crl-to-mrk-s-cough-candidate?cid=CS-ZC-FT-analyst_blog|stock_roundup-2201507
Dec 22, 2023 - FDA approves AstraZeneca (AZN) and Ionis' (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Merck's chronic cough candidate, gefapixant.
0
It's Jobs Week Already? Plus Q4 Reports from MSFT, GOOGL, AAPL, AMZN
https://www.zacks.com/stock/news/2217145/it-s-jobs-week-already-plus-q4-reports-from-msft-googl-aapl-amzn?cid=CS-ZC-FT-ahead_of_wall_street-2217145
Jan 29, 2024 - This week starts slow, but we'll end it with a full-fledged Jobs Week for February. Plus more than half the Magnificent 7 reports earnings.
0
Big Earnings Week Ahead
https://www.zacks.com/stock/news/2217255/big-earnings-week-ahead?cid=CS-ZC-FT-economic_highlights-2217255
Jan 29, 2024 - Big Earnings Week Ahead
0
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More
https://www.zacks.com/stock/news/2241296/pharma-stock-roundup-azn-s-new-acquisition-fda-updates-for-nvo-lly-and-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2241296
Mar 15, 2024 - AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lilly's (LLY) donanemab and approves Novo Nordisk's (NVO) Wegovy for reducing cardiovascular risks.
0
Top Research Reports for Microsoft, Coca-Cola & Accenture
https://www.zacks.com/commentary/2241249/top-research-reports-for-microsoft-coca-cola-accenture?cid=CS-ZC-FT-research_daily-2241249
Mar 15, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Coca-Cola Company (KO) and Accenture plc (ACN).
0
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
https://www.zacks.com/stock/news/2243568/gsk-outperforms-industry-on-strength-in-key-drugs-vaccines?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2243568
Mar 20, 2024 - Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
0
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
https://www.zacks.com/stock/news/2245062/pharma-stock-roundup-azn-to-buy-fusn-pfe-to-sell-stake-in-hln-other-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2245062
Mar 22, 2024 - AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
0